Enormous strides have been made to reduce the risk of transfusion-tran
smitted disease. Additional tests to eliminate transfusion-transmitted
disease are costly, in terms of both health care resources and availa
bility of volunteer donors. Future improvements in safety probably wil
l require postdraw treatment of blood and components and the use of ph
armacologic agents as a substitute for transfusion.